Skip to main content

Table 3 STR profiling of PDX tumor samples

From: Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer

PDX

TH01

D21S11

D5S818

D13S317

D7S820

D16S539

CSF1PO

AMEL

vWA

TPOX

TKO-001_P1

7

7

29

29

7

7

11

11

10

11

11

12

12

12

X

Y

18

18

11

11

TKO-001_P2

7

7

29

29

7

7

11

11

10

11

11

12

12

12

X

Y

18

18

11

11

TKO-002_P1

7

9.3

27

31

13

13

11

12

8

11

9

12

11

11

X

X

16

17

9

9

TKO-002_P2

7

9.3

27

31

13

13

11

12

8

11

9

12

11

11

X

X

16

17

9

9

TKO-003_P1

7

7

29

29

11

12

11

11

10

10

9

9

7

13

X

X

16

16

9

11

TKO-003_P2

7

7

29

29

11

12

11

11

10

10

9

9

7

13

X

X

16

16

9

11

TKO-005_P1

8

9.3

29

31

12

12

12

12

10

10

8

9

10

12

X

X

19

19

8

9

TKO-005_P2

8

9.3

29

31

12

12

12

12

10

10

8

9

10

12

X

X

19

19

8

9

TKO-008_P2

6

6

30

31

13

13

10

10

11

12

9

9

12

12

X

X

17

18

8

8

TKO-008_P1

6

6

30

31

13

13

10

10

11

12

9

9

12

12

X

X

17

18

8

8

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us